Unintended drug interactions with ion channels in cardiac cells can alter normal electrical activity in the heart. This can lead to the onset of cardiac arrhythmias which can be potentially fatal. Such arrhythmias are a leading cause of market withdrawal of pharmaceutical compounds. It is therefore important for pharmaceutical companies to identify drugs which may cause adverse changes to cardiac electrical activity as early as possible in the drug development process.
- Type of award:
- Level of award:
- Awarding institution:
- University of Oxford
- Copyright date:
Mathematical modelling of drug-ion channel interactions for cardiac safety assessment
If you are the owner of this record, you can report an update to it here: Report update to this record